News

Latest news

Hide mandatory notifications of trade

Completion of Subsequent Offering

08.03.2010 - Reference is made to the prospectus dated 18 February 2010 regarding the subsequent offering of up to 10,000,000 Subsequent Offering Shares in Nutri Pharma ASA ("Nutri Pharma") to a price of NOK 2.00 per share, constituting gross proceeds of up to NOK 20,000,000 (the "Subsequent Offering")

This information is subject of the disclosure requirements acc. to §5-12 vphl
(Norwegian Securities Trading Act)
Reference  is  made  to  the  prospectus  dated  18 February  2010 regarding the
subsequent  offering  of  up  to  10,000,000 Subsequent Offering Shares in Nutri
Pharma ASA ("Nutri Pharma") to a price of NOK 2.00 per share, constituting gross
proceeds of up to NOK 20,000,000 (the "Subsequent Offering").

After the expiry of the subscription period at 17:30 hours CET on 4 March 2010,
Nutri  Pharma  has  received  subscriptions  for  a  total of 100,457 Subsequent
Offering  Shares. The Board of  Directors of Nutri Pharma  has resolved to issue
100,457 Subsequent  Offering Shares at NOK 2.00 per share raising gross proceeds
of NOK 200,914.

All  subscribers being allotted Subsequent Offering Shares will receive a letter
confirming  the number of Subsequent Offering  Shares allotted to the Subscriber
and the corresponding amount to be paid. This letter is expected to be mailed on
9 March 2010. Debit of the subscriber's bank account will take place on 11 March
2010, and delivery of the allocated shares is expected to take place on or about
17 March 2010.

Please  note  that  the  subscription  level  may  be  altered  due  to possible
corrections.


FOR FURTHER INFORMATION:
Trond Syvertsen, CEO             +47 23 01 09 60        /
       + 47 91 72 14 57
Lars Helmer Enger, CFO          +47 23 01 09 60        /
       + 47 90 84 37 71


[HUG#1391903]